STEPHANIE LAPIANA: Open Payments
NPI 1477229920 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 39 payments from 15 companies in 2025. Trend: 2023 $1,232 · 2024 $1,416 · 2025 $1,807
Long term medical supply or device loan: $897Food & beverage: $535Education: $374
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $956 |
| ABBVIE INC. | 10 | $331 |
| SEAGEN INC. | 2 | $200 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: KISQALI, VENCLEXTA, EPKINLY, OTEZLA, IBRANCE, TALVEY, Tecentriq, BLENREP.
Industry payments across NY — which companies pay providers there.
